Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
ANNUAL INCOME RANGE
BANK MODIFICATION
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
Suven Pharmaceuticals Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
543064
INE03QK01018
86.6610444
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
SUVENPHAR
109.39
30770.54
EPS(TTM)
Face Value(
)
Div & Yield %:
11.05
1
0
Back
La Opala RG Ltd
La Opala RG Ltd - Disclosure Under Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015
Feb 24,2025
Please find enclosed herewith information in Form- C submitted by one of our Promoter (M/s Genesis Exports Private Limited) under Regulation 7(2) of SEBI (PIT) Regulations 2015 for acquisition of 20000 Equity Shares of the Company. The copy of the disclosure as received by the Company on 22/02/2025 is enclosed herewith for your reference.